A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Biomarker research relies on tissue microarrays (TMA). TMAs are produced by repeated transfer of small tissue cores from a ‘donor’ block into a ‘recipient’ block and then used for a variety of biomarker applications. The construction of conventional TMAs is labor intensive, imprecise, and time-consu...
Main Authors: | Zlobec, Inti, Suter, Guido, Perren, Aurel, Lugli, Alessandro |
---|---|
Format: | Online |
Language: | English |
Published: |
MyJove Corporation
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828107/ |
Similar Items
-
Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types
by: Zlobec, Inti, et al.
Published: (2013) -
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
by: Zlobec, Inti, et al.
Published: (2010) -
TmaDB: a repository for tissue microarray data
by: Sharma-Oates, Archana, et al.
Published: (2005) -
Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
by: Karamitopoulou, Eva, et al.
Published: (2013) -
Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma
by: Wartenberg, Martin, et al.
Published: (2015)